InvestorsHub Logo
Followers 37
Posts 7008
Boards Moderated 1
Alias Born 09/06/2014

Re: Letsdothis85 post# 13226

Wednesday, 06/05/2019 6:14:10 PM

Wednesday, June 05, 2019 6:14:10 PM

Post# of 15647
big news, but not GOOD news.

They answered my questions, sort of:

1. Shandong hasn't done any clinicals yet. They wasted two years.

2. "The study is expected to begin this summer and be completed within three months, after which Shandong will file final paperwork for approval." that puts CFDA clearance, BEST CASE, into Q2 2020, and not much ever goes according to "best case" in the world of developmental biotech.

3. "Shandong has revised its forecast next year upward to include orders of 300 LuViva devices and 3 million disposable Cervical Guides." Sadly, Shandong also revised its forecast THIS year to 0 LuViva devices and 0 disposable Cervical Guides.

China hype. Gene now has another full year of meager revenues while he hangs on hoping for Shandong to suddenly get on their White Horse and start riding.

And no word about whether Gene can use this Chinese clinical to satisfy the US FDA. Which means probably NOT.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GTHP News